The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
Open accessAbstract
Diffuse large B-cell lymphoma (DLBCL) is characterized by a marked degree of morphologic and clinical heterogeneity. Establishment of parameters that can predict outcome could help to identify patients who may benefit from risk-adjusted therapies. BCL-6 is a proto-oncogene commonly implicated in DLBCL pathogenesis. A real-time reverse transcription–polymerase chain reaction assay was established for accurate and reproducible determination of BCL-6 mRNA expression. The method was applied to evaluate the prognostic significance ofBCL-6 expression in DLBCL. BCL-6 mRNA expression was assessed in tumor specimens obtained at the time of diagnosis from 22 patients with primary DLBCL. All patients were subsequently treated with anthracycline-based chemotherapy regimens. These patients could be divided into 2 DLBCL subgroups, one with high BCL-6 gene expression whose median overall survival (OS) time was 171 months and the other with low BCL-6 gene expression whose median OS was 24 months (P = .007). BCL-6 gene expression also predicted OS in an independent validation set of 39 patients with primary DLBCL (P = .01). BCL-6 protein expression, assessed by immunohistochemistry, also predicted longer OS in patients with DLBCL. BCL-6 gene expression was an independent survival predicting factor in multivariate analysis together with the elements of the International Prognostic Index (IPI) (P = .038). By contrast, the aggregate IPI score did not add further prognostic information to the patients' stratification byBCL-6 gene expression. High BCL-6 mRNA expression should be considered a new favorable prognostic factor in DLBCL and should be used in the stratification and the design of risk-adjusted therapies for patients with DLBCL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationHarris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
The Non-Hodgkin's Lymphoma Classification Project (1997) · Blood · doi:10.1182/blood.v89.11.3909 · Cited by 2,461
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
Ye, B. H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., Waard, R. D., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R. S. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0697-161 · Cited by 820
Alterations of a Zinc Finger-Encoding Gene, BCL-6 , in Diffuse Large-Cell Lymphoma
Ye, B. H., Lista, F., Lo Coco, F., Knowles, D. M., Offit, K., Chaganti, R. S. K., & Dalla-Favera, R. (1993) · Science · doi:10.1126/science.8235596 · Cited by 683
BCL-6 protein is expressed in germinal-center B cells
Cattoretti, G., Chang, C., Cechova, K., Zhang, J., Ye, B., Falini, B., Louie, D., Offit, K., Chaganti, R., & Dalla-Favera, R. (1995) · Blood · doi:10.1182/blood.v86.1.45.bloodjournal86145 · Cited by 566
Pasqualucci, L., Migliazza, A., Fracchiolla, N., William, C., Neri, A., Baldini, L., Chaganti, R. S. K., Klein, U., Küppers, R., Rajewsky, K., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11816 · Cited by 536
Gascoyne, R. D., Adomat, S. A., Krajewski, S., Krajewska, M., Horsman, D. E., Tolcher, A. W., O'Reilly, S. E., Hoskins, P., Coldman, A. J., Reed, J. C., et al. (1997) · Blood · doi:10.1182/blood.v90.1.244 · Cited by 509
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
Kramer, M. H. H., Hermans, J., Wijburg, E., Philippo, K., Geelen, E., van Krieken, J. H. J. M., de Jong, D., Maartense, E., Schuuring, E., & Kluin, P. M. (1998) · Blood · doi:10.1182/blood.v92.9.3152 · Cited by 499
Hermine, O., Haioun, C., Lepage, E., d'Agay, M., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J., Diebold, J., et al. (1996) · Blood · doi:10.1182/blood.v87.1.265.265 · Cited by 452
Kerckaert, J.-P., Deweindt, C., Tilly, H., Quief, S., Lecocq, G., & Bastard, C. (1993) · Nature Genetics · doi:10.1038/ng0993-66 · Cited by 427
BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.
Chang, C. C., Ye, B. H., Chaganti, R. S., & Dalla-Favera, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6947 · Cited by 424
Rearrangement of the bcl-6 Gene as a Prognostic Marker in Diffuse Large-Cell Lymphoma
Offit, K., Coco, F. L., Louie, D. C., Parsa, N. Z., Leung, D., Portlock, C., Ye, B. H., Lista, F., Filippa, D. A., Rosenbaum, A., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310202 · Cited by 364
Prognostic significance of survivin expression in diffuse large B-cell lymphomas.
Adida, C., Haïoun, C., Gaulard, P., Lepage, É., Morel, P., Brière, J., Dombret, H., Reyes, F., Diebold, J., Gisselbrecht, C., et al. (2000) · PubMed · doi:10.1182/blood.v96.5.1921 · Cited by 359
Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma.
Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B. H., Knowles, D. M., Offit, K., Chaganti, R. S., & Dalla-Favera, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12520 · Cited by 354
Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
Lo Coco, F., Ye, B., Lista, F., Corradini, P., Offit, K., Knowles, D., Chaganti, R., & Dalla-Favera, R. (1994) · Blood · doi:10.1182/blood.v83.7.1757.1757 · Cited by 317
Hill, M., MacLennan, K., Cunningham, D., Vaughan Hudson, B., Burke, M., Clarke, P., Di Stefano, F., Anderson, L., Vaughan Hudson, G., Mason, D., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1046.1046 · Cited by 314
Bastard, C., Deweindt, C., Kerckaert, J., Lenormand, B., Rossi, A., Pezzella, F., Fruchart, C., Duval, C., Monconduit, M., & Tilly, H. (1994) · Blood · doi:10.1182/blood.v83.9.2423.2423 · Cited by 309
Ye, B. H., Chaganti, S., Chang, C. C., Niu, H., Corradini, P., Chaganti, R. S., & Dalla-Favera, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00311.x · Cited by 277
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma
Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., Saito, H., & Hotta, T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370804 · Cited by 274
BCL-6 expression during B-cell activation
Allman, D., Jain, A., Dent, A., Maile, R., Selvaggi, T., Kehry, M., & Staudt, L. (1996) · Blood · doi:10.1182/blood.v87.12.5257.bloodjournal87125257 · Cited by 252
Lossos, I. S., Alizadeh, A. A., Eisen, M. B., Chan, W. C., Brown, P. O., Botstein, D., Staudt, L. M., & Levy, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316097 · Cited by 251
Self-citationALIZADEH, A., EISEN, M., DAVIS, R. E., MA, C., SABET, H., TRAN, T., POWELL, J. I., YANG, L., MARTI, G. E., MOORE, D. T., et al. (1999) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1999.64.71 · Cited by 247
Self-citationKramer, M. H., Hermans, J., Parker, J., Krol, A. D., Kluin-Nelemans, J. C., Haak, H. L., van Groningen, K., van Krieken, J. H., de Jong, D., & Kluin, P. M. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2131 · Cited by 201
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia.
Capello, D., Vitolo, U., Pasqualucci, L., Quattrone, S., Migliaretti, G., Fassone, L., Ariatti, C., Vivenza, D., Gloghini, A., Pastore, C., et al. (2000) · PubMed · doi:10.1182/blood.v95.2.651 · Cited by 198
Transcriptional repression by the proto-oncogene BCL-6.
Seyfert, V. L., Allman, D., He, Y., & Staudt, L. M. (1996) · PubMed · Cited by 187
Harris, M. B., Chang, C.-C., Berton, M. T., Danial, N. N., Zhang, J., Kuehner, D., Ye, B. H., Kvatyuk, M., Pandolfi, P. P., Cattoretti, G., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7264 · Cited by 186
T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6
Dent, A. L., Hu‐Li, J., Paul, W. E., & Staudt, L. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13823 · Cited by 151
Koduru, P. R. K., Raju, K., Vadmal, V., Menezes, G., Shah, S., Susin, M., Kolitz, J. E., & Broome, J. D. (1997) · Blood · doi:10.1182/blood.v90.10.4078 · Cited by 148
Falini, B., Bigerna, B., Pasqualucci, L., Fizzotti, M., Martelli, M., Pileri, S. A., Pinto, A., Carbone, A., Venturi, S., Pacini, R., et al. (1996) · Blood · doi:10.1182/blood.v87.2.465.bloodjournal872465 · Cited by 132
Otsuki, T., Yano, T., Clark, H., Bastard, C., Kerckaert, J., Jaffe, E., & Raffeld, M. A. (1995) · Blood · doi:10.1182/blood.v85.10.2877.bloodjournal85102877 · Cited by 119
Bindl, J. M., & Warnke, R. A. (1986) · American Journal of Clinical Pathology · doi:10.1093/ajcp/85.4.490 · Cited by 112
Self-citationBcl-6 protein expression in normal and neoplastic lymphoid tissues.
Falini, B., Fizzotti, M., Pileri, S. A., Liso, A., Pasqualucci, L., & Flenghi, L. (1997) · PubMed · Cited by 66
Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B‐cell non‐Hodgkin lymphoma
Chaganti, S. R., Chen, W., Parsa, N. Z., Offit, K., Louie, D. C., Dalla‐Favera, R., & Chaganti, R. S. K. (1998) · Genes Chromosomes and Cancer · Cited by 53
Involvement ofBCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma
Chaganti, S. R., Chen, W., Parsa, N. Z., Offit, K., Louie, D. C., Dalla‐Favera, R., & Chaganti, R. S. K. (1998) · Genes Chromosomes and Cancer · Cited by 48
Cited by
Hans, C. P. (2004) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 3,703
Sehn, L. H., Berry, B., Chhanabhai, M., Fitzgerald, C., Gill, K., Hoskins, P., Klasa, R., Savage, K. J., Shenkier, T., Sutherland, J., et al. (2007) · Blood · doi:10.1182/blood-2006-08-038257 · Cited by 1,473
Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes
Lossos, I. S., Czerwinski, D. K., Alizadeh, A. A., Wechser, M. A., Tibshirani, R., Botstein, D., & Levy, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032520 · Cited by 911
Self-citationColomo, L., López-Guillermo, A., Perales, M., Rives, S., Martı́nez, A., Bosch, F., Colomer, D., Falini, B., Montserrat, E., & Campo, E. (2003) · Blood · doi:10.1182/blood-2002-04-1286 · Cited by 391
Batchelor, T., & Loeffler, J. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8819 · Cited by 362
Metadata
- Authors
- Lossos, I. S., Jones, C. D., Warnke, R., Natkunam, Y., Kaizer, H., Zehnder, J. L., Tibshirani, R., & Levy, R.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2001-08-15
- Volume
- 98
- Issue
- 4
- Pages
- 945-951
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1965527127
- Cited by
- 288
- References
- 38
- FWCI
- 15.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.